Gilstrap Won't Pause $42M Seagen Drug Patent Row For PTAB
U.S. District Judge Rodney Gilstrap has refused to halt post-trial proceedings following a $42 million patent infringement verdict against Daiichi Sankyo, denying its request to wait for the Patent Trial and...To view the full article, register now.
Already a subscriber? Click here to view full article